summary A paradigm shift of candidiasis from Candida albicans to non‐albicans Candida
species has fundamentally increased with the advent of C. auris. C. auris, despite being a …

Candida auris has emerged globally as a multidrug-resistant health care-associated fungal
pathogen. Recent reports highlight ongoing challenges due to organism misidentification …

Candida auris is an invasive fungal pathogen that has been recognized globally as a
serious health threat due to its extensive innate and acquired resistance to antifungal drugs …

Candida auris is an emerging multidrug-resistant fungus that is rapidly spreading worldwide.
Currently, C. auris cases have been reported globally from> 30 countries. Most reported …

Introduction: Candida auris is a recently discovered, rapidly emerging fungal pathogen.
Infections due to C. auris are hospital-acquired, multidrug resistant and associated with high …

The emerging fungal pathogen Candida auris is causing outbreaks of invasive disease in
healthcare facilities around the world [1–4]. Isolates often exhibit resistance to multiple drug …

Candida auris has been described as an emerging yeast species during the last decade. As
many as 25% of its strains may naturally exhibit multi-drug resistance to the currently …

Candida auris is an emerging multidrug-resistant yeast that causes serious invasive
infections with high mortality. It was first discovered in 2009, and since then, individual cases …

First described in 2009 in Japan, the emerging multidrug-resistant fungal pathogen Candida
auris is becoming a worldwide public health threat that has been attracting considerable …

From 2009, Candida auris has emerged as a multidrug‐resistant ascomycete yeast
pathogen with the capacity for easy transmission between patients and hospitals, as well as …